Please Note: This event is free to the public, but the cost for these programs is substantial. If you would like to help support the Ethics Center so that we can continue to offer such programs, please contact us to discuss options for a tax deductible donation.
This program is presented by:
Date & Time
La Jolla Playhouse
Carl June, MD
Carl June is the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine. He is currently Director of Translational Research at the Abramson Cancer Center at the University of Pennsylvania, and is an Investigator of the Abramson Family Cancer Research Institute. He is a graduate of the Naval Academy in Annapolis, and Baylor College of Medicine in Houston, 1979. He had graduate training in Immunology and malaria with Dr. Paul-Henri Lambert at the World Health Organization, Geneva, Switzerland from 1978-79, and post-doctoral training in transplantation biology with Dr. E. Donnell Thomas and Dr. John Hansen at the Fred Hutchinson Cancer Research Center in Seattle from 1983 - 1986. He is board certified in Internal Medicine and Medical Oncology. He founded the Immune Cell Biology Program and was head of the Department of Immunology at the Naval Medical Research Institute from 1990 to 1995 before joining the faculty of the Perelman School of Medicine in 1999. He maintains a research laboratory that studies various mechanisms of lymphocyte activation that relate to immune tolerance and adoptive immunotherapy for cancer and chronic infection. He has published more than 300 manuscripts and is the recipient of numerous prizes and honors, including election to the Institute of Medicine in 2012, the William B Coley award, and the Richard V Smalley Memorial Award from the Society for Immunotherapy of Cancer in 2013. In 2014, Dr. June is considered the most influential academic scientist in the biopharmaceutical industry.
Garth Powis D.Phil., Moderator
Garth Powis is professor and director of Sanford Burnham's National Cancer Institute-designated Cancer Center. He holds the Jeanne and Gary Herberger Leadership Chair in Cancer Research. He came to the Insitute from MD Anderson Cancer Center, where he was chair of Experimental Therapeutics and director of the Center for Targeted Therapy. He has more than 350 publications and 15 patents, and his work has resulted in three new cancer drugs currently in clinical trials.
Targeted Immunotherapy to Revolutionize Cancer Treatment
Dr. June will discuss the emergence of immunotherapy as an approach to treat cancer. The approach is less toxic than many previous forms of therapy and when effective, has long term effects that appear to be curative. Advances have occurred in blood cancers, skin cancers such as melanoma and in other previously untreatable cancers such as metastatic lung cancer. Some of the barriers and challenges to bringing this paradigm shifting treatment into routine medical practice will be discussed.
Guests are not required to print their tickets.
Located on the UCSD Campus via the Revelle College Drive entrance, off La Jolla Village Drive.
Park in lot to the left of the theatres. Note your space number, and pay the $2 parking fee at the pay station.
Pay stations accept Visa, MasterCard, American Express or cash ($1 and $5), and do not give change. You will not need to return to your car.